• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, January 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Australian GPs widely offering placebos, new study finds

Bioengineer by Bioengineer
December 2, 2019
in Health
Reading Time: 4 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Active and inactive alternatives offered to patients

IMAGE

Credit: University of Sydney

Most Australian GPs have used a placebo in practice at least once, with active placebos (active treatments used primarily to generate positive expectations) more commonly used than inert placebos, according to a new study.

International studies indicate that placebo use by general practitioners (GPs) is remarkably high, but until now usage in Australia was unknown.

A new survey by Associate Professor Ben Colagiuri, in the School of Psychology at the University of Sydney, and Dr Kate Faasse at the University of New South Wales, examined rates of use and beliefs about placebos in Australian general practice. The findings are published today in the journal The Australian Journal of General Practice.

Key findings:

  • 77% of GPs had offered an active placebo (such as antibiotics for a virus)
  • 39% of GPs had offered an inert placebo (such as saline spray or a water-based cream)
  • GPs primarily used placebos because they believed they could provide genuine benefit and viewed themselves as having a strong role in shaping patients’ expectations
  • 53% of GPs felt that administering placebos deceptively was unethical, but most (>80%) believed openly providing placebos – ie with the patient’s knowledge – is ethical
  • GPs felt that medical trainees would benefit from more education about placebos

“We already know that doctors and GPs use placebos regularly overseas,” Associate Professor Ben Colagiuri said. “So, we wanted to see what was happening in Australia. We found that placebo use is also relatively common here. The good news is that Australian GPs are predominantly using placebos because they believe that there’s some real benefit to them. They are simply trying to help their patients.”

The more concerning news, Associate Professor Colagiuri said, is that in some cases GPs are also prescribing antibiotics, an active medication, for purposes other than its design.

“The most common case is when a GP prescribes antibiotics when they know or strongly suspect that the patient doesn’t have a bacterial infection,” he said. “In these cases, they are prescribing antibiotics as a type of placebo, often because a patient expects or demands treatment. But antibiotics can have side effects and there are problems with antibiotic resistance if we prescribe antibiotics too much.”

According to Associate Professor Colagiuri, one of the most important findings coming from the study is that GPs felt that medical trainees could benefit from more education about the placebo effect. “Currently, there are no guidelines on placebo use in clinical practice in Australia. As such, GPs and other medical professionals are left to make up their own minds as to if, at all, and how to use placebos. It is really important for medical professionals and patients that we develop evidenced-based guidelines for placebo use in Australia.”

Co-author Dr Kate Faasse, from the School of Psychology at UNSW said the study found rates of placebo use by Australian GPs that were similar to those seen in other countries – the rates of use that we are seeing in the current study are very much in line with international research.

“Now we need more focus on understanding the role of psychological and social factors in physical health outcomes,” Dr Faasse said. “There is so much more than just the active ingredients of a medicine, for example, that can help to improve people’s health.”

“In terms of future research, I think the possibility that we – either as individuals, or in medical contexts – can be harnessing the placebo effect in our own lives by knowingly using ‘open-label’ placebos is fascinating,” Dr Fasse said. “Figuring out the best way to do this, for example what information helps open-label placebos be most effective, in what dose, and for what outcomes, are really fascinating research questions that we’re starting to explore.”

What is a placebo?

A placebo is a treatment that works because the patient expects it to. Placebos have been found to produce genuine therapeutic benefit in conditions ranging from pain, nausea and sleep, to hypertension, immune function and even Parkinson’s disease.

An inert placebo treatment is something that has no active ingredients whatsoever, such as a sugar pill, saline nasal spray or a water-based cream. An active placebo treatment is one that contains active ingredients – an antibiotic or cough mixture – but is unlikely to have a specific physiological effect on the patient’s current condition.

What is the placebo effect?

The placebo effect occurs when the patient believes a treatment will help them to feel better. These beliefs trigger changes in the central nervous system – such as the release of neurotransmitters in our brains – that actually cause improvement. Usually placebos involve deception, that is the patient is led to believe that they are receiving an active treatment. However, recent studies have shown that the placebo effect can happen even when the patient knows they are receiving a placebo. The vast majority of Australian GPs – more than 80 per cent – believe that giving a placebo openly, without deception, is ethical.

###

The study

The study published in the journal The Australian Journal of General Practice involved a random sample of 136 GPs from around Australia who completed a brief online survey which asked them about placebo use and their beliefs about placebo treatments.

Declaration: Funding: Dr Faasse is supported by an Australian Research Council Discovery Early Career Researcher Award (DE180100471). Associate Professor Colagiuri was supported by an Australian Research Council Discovery Early Career Researcher Award (DE160100864) while conducting this research. The funder played no part in the study design, data collection, analysis, or interpretation. The researchers are independent from the funder.

Media Contact
Elissa Blake
[email protected]
61-408-565-604

Original Source

https://sydney.edu.au/news-opinion/news/2019/12/02/placebo-use-among-australian-gps-surprisingly-high.html

Related Journal Article

http://dx.doi.org/10.31128/AJGP-11-18-4755

Tags: Medical/Scientific EthicsMedicine/HealthMental HealthPerception/AwarenessPublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Advancing Research: Aging Meets Parkinson’s Disease Models

January 16, 2026

Radiofrequency Echographic Multispectrometry vs. Dual X-ray for Osteoporosis

January 16, 2026

Alpha Lipoic Acid’s Impact on Psoriasis Inflammation

January 16, 2026

From Childhood to Adulthood: Sports Betting Risks

January 16, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    155 shares
    Share 62 Tweet 39
  • PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    147 shares
    Share 59 Tweet 37
  • Robotic Ureteral Reconstruction: A Novel Approach

    77 shares
    Share 31 Tweet 19
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    54 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Impact of Fuel-Cut Events on Catalyst Aging

Advancing Perovskite Solar Cells via CIGS Insights

Smart Energy Governance for Resilient Solar Data Centers

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.